Thermo Fisher Scientific Statistics
Share Statistics
Thermo Fisher Scientific has 382.50M shares outstanding. The number of shares has increased by 0.31% in one year.
| Shares Outstanding | 382.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.13% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 381.97M |
| Failed to Deliver (FTD) Shares | 5 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 3.96M, so 1.03% of the outstanding shares have been sold short.
| Short Interest | 3.96M |
| Short % of Shares Out | 1.03% |
| Short % of Float | 1.04% |
| Short Ratio (days to cover) | 1.71 |
Valuation Ratios
The PE ratio is 34.18 and the forward PE ratio is 23.06. Thermo Fisher Scientific 's PEG ratio is 0.43.
| PE Ratio | 34.18 |
| Forward PE | 23.06 |
| PS Ratio | 4.78 |
| Forward PS | 4.4 |
| PB Ratio | 4.38 |
| P/FCF Ratio | 29.58 |
| PEG Ratio | 0.43 |
Enterprise Valuation
Thermo Fisher Scientific Inc. has an Enterprise Value (EV) of 231.72B.
| EV / Earnings | 38.65 |
| EV / Sales | 5.41 |
| EV / EBITDA | 20.92 |
| EV / EBIT | 33.78 |
| EV / FCF | 33.45 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.75.
| Current Ratio | 1.75 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.75 |
| Total Debt / Capitalization | 42.76 |
| Cash Flow / Debt | 0.24 |
| Interest Coverage | 4.99 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 8.01%.
| Return on Equity (ROE) | 0.13% |
| Return on Assets (ROA) | 0.06% |
| Return on Capital (ROIC) | 8.01% |
| Revenue Per Employee | 351.29K |
| Profits Per Employee | 49.14K |
| Employee Count | 122.00K |
| Asset Turnover | 0.43 |
| Inventory Turnover | 5.06 |
Taxes
| Income Tax | 284.00M |
| Effective Tax Rate | 0.05 |
Stock Price Statistics
The stock price has increased by 2.81% in the last 52 weeks. The beta is 0.79, so Thermo Fisher Scientific 's price volatility has been higher than the market average.
| Beta | 0.79 |
| 52-Week Price Change | 2.81% |
| 50-Day Moving Average | 531.94 |
| 200-Day Moving Average | 570.41 |
| Relative Strength Index (RSI) | 67.2 |
| Average Volume (20 Days) | 1.85M |
Income Statement
In the last 12 months, Thermo Fisher Scientific had revenue of 42.86B and earned 6.00B in profits. Earnings per share was 15.53.
| Revenue | 42.86B |
| Gross Profit | 17.11B |
| Operating Income | 6.86B |
| Net Income | 6.00B |
| EBITDA | 11.08B |
| EBIT | 6.86B |
| Earnings Per Share (EPS) | 15.53 |
Balance Sheet
The company has 8.08B in cash and 34.92B in debt, giving a net cash position of -26.84B.
| Cash & Cash Equivalents | 8.08B |
| Total Debt | 34.92B |
| Net Cash | -26.84B |
| Retained Earnings | 47.36B |
| Total Assets | 100.36B |
| Working Capital | 9.18B |
Cash Flow
In the last 12 months, operating cash flow was 8.41B and capital expenditures -1.48B, giving a free cash flow of 6.93B.
| Operating Cash Flow | 8.41B |
| Capital Expenditures | -1.48B |
| Free Cash Flow | 6.93B |
| FCF Per Share | 17.95 |
Margins
Gross margin is 39.93%, with operating and profit margins of 16% and 13.99%.
| Gross Margin | 39.93% |
| Operating Margin | 16% |
| Pretax Margin | 14.7% |
| Profit Margin | 13.99% |
| EBITDA Margin | 25.85% |
| EBIT Margin | 16% |
| FCF Margin | 16.16% |
Dividends & Yields
TMO pays an annual dividend of $1.56, which amounts to a dividend yield of 0.28%.
| Dividend Per Share | $1.56 |
| Dividend Yield | 0.28% |
| Dividend Growth (YoY) | 11.43% |
| Payout Ratio | 9.79% |
| Earnings Yield | 2.79% |
| FCF Yield | 3.25% |
Analyst Forecast
The average price target for TMO is $650, which is 16.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $650 |
| Price Target Difference | 16.6% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
Stock Splits
The last stock split was on Jun 6, 1996. It was a forward split with a ratio of 3:2.
| Last Split Date | Jun 6, 1996 |
| Split Type | forward |
| Split Ratio | 3:2 |
Scores
| Altman Z-Score | 3.9 |
| Piotroski F-Score | 5 |